Bio production CMO & CRO Market by Products (Biologics, Antisense, RNAi, & Molecular Therapy And Bio similar) by Services (Contract Manufacturing And Contract Research) by Application (Oncology, Inflammation & Immunology, Cardiology, Neuroscience) Global Opportunity Analysis and Industry Forecast, 2020 – 2030
The Global Bio production CMO & CRO Market size is estimated to be USD 24.20 billion in 2019 and is predicted to reach USD 51.46 billion by 2030 with a CAGR of 7.1% from 2020-2030. The pharmaceutical and biotechnology companies are currently focusing on outsourcing their research and development, manufacturing and distribution needs to contract manufacturers and contract research organizations. These partnerships mainly focus towards core competencies and gaining access to skilled expertise and robust analytical tools in order to bring quality products in the market.
Outsourcing and consolidation are common terms associated with today’s mature manufacturing sectors. Despite continuous innovations in the healthcare and bio pharma industry, the pharmaceutical and biotechnology companies are short of significant manufacturing and logistics facilities. Outsourcing these services help these companies to realign their strategic priorities. Moreover, the contract manufacturers have adapted and made use of opportunities provided to them by both small and large companies, which has shaped the industry. CMOs and CROs supports the bio pharma companies by providing guidance through skilled personnel and adequate sites and equipment in terms of regulations and technology.
Market Dynamics and Trends:
The development of biological products has increased tremendously in past few years. This substantial growth in the manufacturing sector demands larger and more appropriate manufacturing capabilities, based on which bioproduction activities are increasingly being outsourced and budgets are increasing. Moreover, increasing investments in establishments of new manufacturing facilities and enhancement of production capabilities fuels the growth of this bio production CMO & CRO market. Adoption of innovative technologies help contract manufacturers to provide adequate services to the industry giants, however many well-established players keep their production in-house as production of large molecules is technologically complex. Also, several companies are expanding their in-house production capabilities, which is expected to impact on the growth of bioproduction CMO & CRO market.
CROs and CMOs are creating a new benchmark for the effective production of biopharmaceuticals including biologics and biosimilars. Number of tradional drug developers are making strategic alliances and collaborations to with contract manufacturers and researchers to enhance their existing product portfolio. For instance, in April 2015 Sartorius Stedim Biotech acquired UK-Based CRO, BioOutsource. This acquisition enables the company to provide contract testing services to global biopharmaceutical clients in order to monitor the safety and quality of biologic drugs and vaccines. Also, in December 2016, Accinov merged with a Canadian CRO, Biodextris. Such developments provides the companies access to novel technologies and also enhances their client base.
Market Segmentations and Scope of the Study:
The bio production CMO & CRO market share is analyzed on the basis of products, services, application and geography. On the basis of product, the bio production CMO & CRO market is segmented into biologics, antisense, RNAi, & molecular therapy and biosimilars. By services the market is segmented into contract manufacturing and contract research. The application segment includes oncology, inflammation & immunology, cardiology, neuroscience and others. Geographic breakdown and deep analysis of each of the aforesaid segments is included for North America, Europe, Asia-Pacific, and Rest of the World.
Competitive Landscape:
Comprehensive competitive analysis and profiles of major market players such as Lonza, Boehringer Ingelheim, FUJIFILM Diosynth Biotechnologies U.S.A., Samsung BioLogics, AbbVie Inc., Patheon, Inno Biologics Sdn Bhd, TOYOBO CO., LTD., Binex Co., Ltd., and WuXi Biologics is also provided in this report.
KEY PLAYERS
- Lonza
- Boehringer Ingelheim
- FUJIFILM Diosynth Biotechnologies U.S.A.
- Samsung BioLogics
- AbbVie Inc.
- Patheon
- Inno Biologics Sdn Bhd
- TOYOBO CO., LTD.
- Binex Co., Ltd.
- WuXi Biologics
At Next Move Strategy Consulting, we understand that insightful market research is the cornerstone of successful business decisions. That's why we employ a robust and multifaceted approach, combining various methodologies to deliver the most accurate and actionable data for our clients.
Research Landscape
We navigate the world of research with two primary approaches:
Qualitative Approach
Our qualitative research methodologies involve immersive techniques such as in-depth interviews, focus groups, and observational studies. By engaging directly with individuals and stakeholders, we uncover valuable insights that quantitative data alone may overlook.
Quantitative Research
In tandem with qualitative methodologies, NMSC leverages the power of Quantitative Research to provide a robust foundation of numerical insights. Through systematic data collection and analysis, we quantify patterns, preferences, and market trends, offering a comprehensive view of the business landscape.
Our quantitative research approach employs diverse tools, including surveys, experiments, and statistical modelling. These methodologies enable us to gather data from a large and representative sample, ensuring the statistical significance of our findings. By employing structured questionnaires and standardized data collection methods, we guarantee the reliability and validity of the information we present to our clients.
Quantitative research is particularly effective in measuring the prevalence of trends, assessing market size, and gauging the impact of various factors on consumer behavior. The numerical precision attained through this approach equips our clients with actionable insights, facilitating data-driven decision-making and strategy formulation.
Our Specialized Toolbox for Industry-Specific Market Research
We deploy a specialized arsenal of techniques tailored to meet your unique requirements. Here's a glimpse into our comprehensive toolbox:
Information Procurement
The stage entails acquiring market data or relevant information through various sources and methodologies.
Market Research Approach
We utilize both top-down and bottom-up approaches in market research analysis to achieve a comprehensive understanding of the market dynamics, leveraging the broad perspective of industry trends and macroeconomic factors alongside detailed insights from specific segments and individual companies.
Porters Five Forces Analysis
We conduct Porter's Five Forces analysis to evaluate the competitive landscape of an industry, providing us with insights into factors that affect profitability and strategic positioning.
SWOT Analysis
We conduct SWOT analysis to understand market trends, identify potential threats, capitalize on opportunities, and assess our strengths and weaknesses.
Forecasting
We utilize a forecasting model to predict future consumption by considering parameters like population, economics, regulations, market competition, drivers, constraints, technology, and pricing. We also employ statistical techniques such as multilinear regression, exponential smoothing, moving average, ARIMA, and Monte Carlo simulations for accurate predictions. In econometric forecasting, we analyzed short-term and long-term event impacts, attributing values based on regulatory frameworks, economic factors, and market events.
Download Free Sample
Frequently Asked Questions
Speak to Our Analyst
Related Report
Related Blogs
A Performance Analysis on Key Players Operating in the Global Early Toxicity Testing Industry
Our analysis indicates substantial growth in the global earl...
From Breakouts to Breakthroughs: The Future of Acne Treatment
Introduction Acne, a universal skin concern, often seems like an unwelcome gu...
